142 related articles for article (PubMed ID: 3798631)
1. Clinical evaluation of flutamide and estramustine as initial treatment of metastatic carcinoma of prostate.
Johansson JE; Andersson SO; Beckman KW; Lingårdh G; Zador G
Urology; 1987 Jan; 29(1):55-9. PubMed ID: 3798631
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation with long-term follow-up of flutamide and estramustine as initial treatment of metastatic carcinoma of the prostate.
Johansson JE; Andersson SO; Beckman KW; Zador G
Am J Clin Oncol; 1988; 11 Suppl 2():S183-6. PubMed ID: 3242386
[TBL] [Abstract][Full Text] [Related]
3. Comparison of flutamide and Emcyt in hormone-refractory metastatic prostatic cancer.
de Kernion JN; Murphy GP; Priore R
Urology; 1988 Apr; 31(4):312-7. PubMed ID: 3281365
[TBL] [Abstract][Full Text] [Related]
4. [Complete androgen blockade (orchiectomy + flutamide) versus androgen blockade with cytostasis (orchiectomy + estramustine) in the treatment of virginal advanced prostate cancer].
Flamm J; Fischer M
Wien Klin Wochenschr; 1988 Sep; 100(17):589-92. PubMed ID: 3055689
[TBL] [Abstract][Full Text] [Related]
5. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
Nickel CJ; Morales A
Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
[TBL] [Abstract][Full Text] [Related]
6. Estramustine phosphate as primary therapy for metastatic prostate cancer. Preliminary results of the University of Wisconsin trial.
Benson RC
Urology; 1984 Jun; 23(6 Suppl):69-72. PubMed ID: 6375084
[No Abstract] [Full Text] [Related]
7. Relationship of prior hormonal therapy to subsequent estramustine phosphate treatment in advanced prostatic cancer.
Slack NH; Wajsman Z; Mittelman A; Bruno S; Murphy GP
Urology; 1979 Dec; 14(6):549-54. PubMed ID: 390810
[TBL] [Abstract][Full Text] [Related]
8. Estramustine phosphate in the treatment of advanced prostatic cancer.
Küss R; Khoury S; Richard F; Fourcade F; Frantz P; Capelle JP
Br J Urol; 1980 Feb; 52(1):29-33. PubMed ID: 7426949
[TBL] [Abstract][Full Text] [Related]
9. Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy.
Sogani PC; Vagaiwala MR; Whitmore WF
Cancer; 1984 Aug; 54(4):744-50. PubMed ID: 6378356
[TBL] [Abstract][Full Text] [Related]
10. Experience in advanced prostatic cancer: orchiectomy and flutamide versus orchiectomy and estramustine phosphate.
Roessler W; Hinke A; Wieland WF
Urology; 1994 Feb; 43(2 Suppl):57-60. PubMed ID: 8116134
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
[No Abstract] [Full Text] [Related]
12. Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.
Andersson L; Berlin T; Boman J; Collste L; Edsmyr F; Esposti PL; Gustafsson H; Hedlund PO; Hultgren L; Leander G; Nordle O; Norlén H; Tillegård P
Scand J Urol Nephrol Suppl; 1980; 55():143-5. PubMed ID: 6259722
[TBL] [Abstract][Full Text] [Related]
13. Flutamide as primary treatment for metastatic prostatic cancer.
Lundgren R
Br J Urol; 1987 Feb; 59(2):156-8. PubMed ID: 3828712
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced carcinoma of the prostate with estramustine phosphate.
Fosså SD; Miller A
J Urol; 1976 Apr; 115(4):406-8. PubMed ID: 1263316
[TBL] [Abstract][Full Text] [Related]
16. Experience with flutamide in previously untreated patients with advanced prostatic cancer.
Sogani PC; Whitmore WF
J Urol; 1979 Nov; 122(5):640-3. PubMed ID: 501817
[TBL] [Abstract][Full Text] [Related]
17. [Value of estramustine phosphate in the treatment of estrogen-resistant prostatic adenocarcinoma].
Toulouse J; Jung JL; Bittard M
J Urol (Paris); 1984; 90(1):27-33. PubMed ID: 6725973
[TBL] [Abstract][Full Text] [Related]
18. Estramustine phosphate (Estracyt) treatment of T3-T4 prostatic carcinoma.
Veronesi A; Zattoni F; Frustaci S; Galligioni E; Tirelli U; Trovó G; Tumolo S; Merlo A; Artuso G; Cosciani-Cunico S; Grigoletto E
Prostate; 1982; 3(2):159-64. PubMed ID: 7088731
[TBL] [Abstract][Full Text] [Related]
19. A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area.
Soloway MS; Beckley S; Brady MF; Chu TM; deKernion JB; Dhabuwala C; Gaeta JF; Gibbons RP; Loening SA; McKiel CF; McLeod DG; Pontes JE; Prout GR; Scardino PT; Schlegel JU; Schmidt JD; Scott WW; Slack NH; Murphy GP
J Urol; 1983 Jan; 129(1):56-61. PubMed ID: 6338251
[TBL] [Abstract][Full Text] [Related]
20. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate.
Chisholm GD; O'Donoghue EP; Kennedy CL
Br J Urol; 1977; 49(7):717-20. PubMed ID: 339986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]